Ignite Creation Date:
2024-05-05 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00197405
Status:
UNKNOWN
Last Update Posted:
2009-08-04
First Post:
2005-09-12
Brief Title:
Comparison of Fecal Ribonucleic Acid RNA Test With Fecal Occult Blood Test FOBT for Detecting Colorectal Cancer and Adenoma
Sponsor:
Hamamatsu University
Organization:
Hamamatsu University
Study Overview
Official Title:
Comparative Study of Fecal RNA Test With Immunochemical Fecal Occult Blood Test for Detecting Colorectal Cancer and Adenoma
Status:
UNKNOWN
Status Verified Date:
2009-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Colorectal cancer CRC is the second common cause of death in the Western world and is very increasing in Japan Fecal occult blood test FOBT is used routinely for CRC screening which has been shown to reduce the incidence morbidity and mortality of CRC However there is a need to develop a novel method to improve sensitivity The investigators reported that Fecal COX-2 assay one of fecal RNA test is potentially useful for colorectal cancer screening Gastroenterology 127 422-427 2004 So the investigators planed to compare fecal RNA test with FOBT for detecting colorectal cancer and adenoma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None